Reposted by Cambridge Clinical Mitochondrial Research Group
An exciting advance for patients with #mitochondrialdisease as new drug gets fast tracked! See more below from Pretzel Therapeutics as they tackle #POLG #mitochondrialdysfunction :
lnkd.in/p/gftQnsCD
#mitocanda #UMDF #mitoscientists #mitochondria #mtDNA #mitochondrialtherapy
lnkd.in
Pretzel Therapeutics Receives FDA Fast Track Designation for PX578 for the Treatment of POLG-mediated Primary Mitochondrial Disorders | Pretzel Therapeutics
Another meaningful step forward for patients living with POLG disease.
We’re proud to announce that the U.S. FDA has granted Fast Track designation to PX578, our investigational, first-in-class PO...